CAR T-cell therapy is expected to expand quickly across autoimmune skin diseases following an anticipated regulatory approval that might come as soon as this year.

University of Queensland researchers have developed a drug that activates a hard-to-target immune receptor—a breakthrough ...

Celea, backed by investors such as RA Capital and Leaps by Bayer, is making what it says is an improved version of Roche's ...

Sialic acid is a natural sugar building block found on the surfaces of our cells. It acts as a protective and recognition molecule and plays a central role in the development of the nervous system.

Led by NYU Langone Health researchers, a new study shows how blood cancer cells enter the lungs, damage tissue, and cause ...

Two receptors work together to control how trees make wood, a finding that could improve carbon storage and timber production ...

International nanoscientists publish a new blueprint reframing the protein corona as a programmable navigation interface to cross the blood-brain barrier.

Researchers at Weill Cornell Medicine, Cedars-Sinai Medical Center, and Roswell Park Comprehensive Cancer Center have developed genetically engineered CAR T cells that specifically target and kill ...

A new study frames TREM-1 as an upstream innate immune amplifier, mapping out a new therapeutic target for sepsis, arthritis, and neurodegeneration.

Researchers say newly identified cholesterol control pathway is completely separate from anything targeted by existing drugs.

Researchers from the Biosciences Department at Durham University have discovered a previously unknown mechanism that helps plants control the formation of wood, a finding that could open new ...

The benefits of dietary fiber extend beyond digestive health, as dietary fiber-derived metabolites produced by gut microbiota ...